Literature DB >> 16225713

Medical nebulizer performance: effects of cascade impactor temperature.

Yue Zhou1, Amitkumar Ahuja, Clinton M Irvin, Dean A Kracko, Jacob D McDonald, Yung-Sung Cheng.   

Abstract

BACKGROUND: During operation of a jet nebulizer, the temperature of the nebulizer outlet could decrease by more than 10 degrees C, depending on the nebulizer type and operating conditions, such as driving flow rate and fill volume. The droplet size distribution generated from the nebulizer can be measured by a cascade impactor. However, when the cascade impactor is operated at ambient room temperature, the droplets could evaporate because of the temperature difference between the nebulizer outlet and the body of the impactor.
METHODS: An 8-stage cascade impactor was used to measure the particle size distribution from 4 different types of jet nebulizer (LC Plus, Side-Stream, VixOne, and Micromist) in 2 temperature conditions: ambient (22 degrees C) and low (10 degrees C). Two different formulations, albuterol (aqueous solution) and budesonide (suspension), were used.
RESULTS: There was a significantly larger (p < 0.05) mass median aerodynamic diameter and smaller respirable fraction for each nebulizer with the impactor at low temperature than with the impactor at ambient temperature. The mass median aerodynamic diameter of the nebulizers with the impactor operating at low temperature appeared 15-130% larger than with the impactor operating at ambient temperature, for both formulations. The respirable fraction also changed from 10% when the impactor was operated at low temperature to 65% when the impactor was operated at ambient temperature.
CONCLUSION: The results provide important information for the use of a cascade impactor to measure the particle-size distribution of nebulizer aerosols.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16225713

Source DB:  PubMed          Journal:  Respir Care        ISSN: 0020-1324            Impact factor:   2.258


  3 in total

1.  Humidified and Heated Cascade Impactor for Aerosol Sizing.

Authors:  Caroline Majoral; Allan L Coates; Alain Le Pape; Laurent Vecellio
Journal:  Front Bioeng Biotechnol       Date:  2020-11-13

2.  An aerosol formulation of R-salbutamol sulfate for pulmonary inhalation.

Authors:  Xuemei Zhang; Qing Liu; Junhua Hu; Ling Xu; Wen Tan
Journal:  Acta Pharm Sin B       Date:  2014-01-18       Impact factor: 11.413

3.  How Cold Is Cold Enough? Refrigeration of the Next-Generation Impactor to Prevent Aerosol Undersizing.

Authors:  Uwe Schuschnig; Benjamin Heine; Martin Knoch
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2021-06-07       Impact factor: 2.849

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.